Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo - PubMed (original) (raw)
Randomized Controlled Trial
. 2006 Jan 4;81(1):27-36.
doi: 10.1016/j.drugalcdep.2005.05.003. Epub 2005 Jun 21.
Affiliations
- PMID: 15975736
- DOI: 10.1016/j.drugalcdep.2005.05.003
Randomized Controlled Trial
Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo
Chris-Ellyn Johanson et al. Drug Alcohol Depend. 2006.
Abstract
In animals, two-choice drug discrimination studies have demonstrated that the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) are mediated by dopaminergic and serotonergic systems. In order to delineate the relative role of these systems, three-choice paradigms have been used in animals, with findings indicating a more prominent role for serotonin. Human studies assessing the subjective and physiological effects of MDMA have also indicated a mixed action. To parallel animal studies, the participants in the present study were trained to discriminate among a prototypic dopaminergic agonist, d-amphetamine, a prototypic serotonergic agonist, meta-chlorophenylpiperazine (mCPP) and placebo and then were tested with two doses of MDMA. In addition, subjective and physiological effects were measured. The results demonstrated that humans could be trained to discriminate among 20 mg d-amphetamine, 0.75 mg/kg mCPP and placebo. When tested with 1.0 and 1.5 mg/kg, half the participants reported MDMA to be like amphetamine and half like mCPP. There were no clear differences between these two groups in other dimensions, although there was an indication that the individuals who discriminated MDMA as d-amphetamine were more sensitive to the effects of all the drugs. The subjective effects of all three drugs overlapped, although the effects of MDMA appeared more amphetamine-like.
Similar articles
- Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP.
Tancer M, Johanson CE. Tancer M, et al. Drug Alcohol Depend. 2003 Oct 24;72(1):33-44. doi: 10.1016/s0376-8716(03)00172-8. Drug Alcohol Depend. 2003. PMID: 14563541 - Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A. Thomasius R, et al. J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review. - Ecstasy: are animal data consistent between species and can they translate to humans?
Easton N, Marsden CA. Easton N, et al. J Psychopharmacol. 2006 Mar;20(2):194-210. doi: 10.1177/0269881106061153. J Psychopharmacol. 2006. PMID: 16510478 Review.
Cited by
- The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Tancer M, Johanson CE. Tancer M, et al. Psychopharmacology (Berl). 2007 Jan;189(4):565-73. doi: 10.1007/s00213-006-0576-z. Epub 2006 Oct 18. Psychopharmacology (Berl). 2007. PMID: 17047932 Clinical Trial. - Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat.
Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA. Baumann MH, et al. Drug Metab Dispos. 2009 Nov;37(11):2163-70. doi: 10.1124/dmd.109.028506. Epub 2009 Aug 13. Drug Metab Dispos. 2009. PMID: 19679675 Free PMC article. - Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA. Concheiro M, et al. Drug Metab Dispos. 2014 Jan;42(1):119-25. doi: 10.1124/dmd.113.053678. Epub 2013 Oct 18. Drug Metab Dispos. 2014. PMID: 24141857 Free PMC article. - Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys.
McClung J, Fantegrossi W, Howell LL. McClung J, et al. Psychopharmacology (Berl). 2010 May;210(1):75-83. doi: 10.1007/s00213-010-1818-7. Epub 2010 Mar 23. Psychopharmacology (Berl). 2010. PMID: 20309529 Free PMC article. - The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.
Kamilar-Britt P, Bedi G. Kamilar-Britt P, et al. Neurosci Biobehav Rev. 2015 Oct;57:433-46. doi: 10.1016/j.neubiorev.2015.08.016. Epub 2015 Sep 25. Neurosci Biobehav Rev. 2015. PMID: 26408071 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical